ACTRN12624000456550尚未招募Unknown
A Randomised Controlled Trial of the Efficacy of Internet-Based Cognitive Behaviour Therapy plus messaging support for managing child and adolescent anxiety in regional communities
niversity of Southern Queensland0 个研究点目标入组 150 人开始时间: 2024年4月15日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 7 Years 至 17 Years（—）
- 性别
- All
入选标准
- •Children and adolescents will be invited to participate in the study if they meet the following criteria at initial registration for the Momentum platform;
- •(1) if they present with elevated levels of anxiety on the Spence Children’s Anxiety Scale (equal or greater than 84th percentile or T-score of 60);
- •(2) are residents of regional/rural areas (as classified by areas 2-7 of the Modified Monash Model, identified via postcode);
- •(3) do not demonstrate clinically interfering depression levels on the Centre for Epidemiological Studies Depression Scale for Children. Clinically interfering levels are defined as meeting the 'elevated' cut-off on this scale AND rating the degree of interference from the depression at a minimum of 5 or higher on an 8-point scale;
- •(4) have access to the Momentum online platform via a computer or mobile device with an Australian IP address;
- •(5) aged 7-17 years;
- •Additional inclusion criteria (ascertained via interview):
- •(1) a primary diagnosis of social anxiety disorder (SAD), generalised anxiety disorder (GAD), separation anxiety (SEP), or specific phobia (SP) on the Anxiety Disorders Interview Schedule for Children – Child and Parent version (ADIS-C/P; Silverman and Albano, 1996);
- •(2) willingness to be randomised to one of the two conditions.
- •Children and adolescents with a primary diagnosis of obsessive-compulsive disorder (OCD), posttraumatic disorder (PTSD) or panic disorder (PD) will not be eligible for participation. However, these diagnoses will be permitted if secondary. Participants with secondary mood disorders will be included, provided that their mood disturbance had a clinician severity rating (CSR) of <5 on the ADIS-C/P.
排除标准
- •Children and adolescents with current suicidal ideation, self-harm tendencies, substance abuse issues, significant behavioural disorders, pervasive developmental disorders, learning disorders, or those currently receiving professional help, as well as those who initiated or altered medication for anxiety or sleep within the six weeks leading up to the baseline assessment, will be excluded from the study.
研究者
相似试验
尚未招募
2 期
Tenecteplase versus Alteplase before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)ACTRN12615000220561euroscience Trials Australia64
尚未招募
2 期
Effectiveness of Salbutamol in treatment of TTNB- A RCT STUDYCTRI/2023/09/057567Department of pediatrics INHS ASVINI
已完成
不适用
Randomized controlled trial on the efficacy of the prolonged exposure therapy for PTSDJPRN-UMIN000001183ational Institute of Mental Health, National Center of Neurology and Psychiatry40
已完成
不适用
Randomized controlled trial on the efficacy of the Trauma-Focused Cognitive Behavioral Therapy for children with posttraumatic stress disorderJPRN-UMIN000010699Hyogo Earthquake Memorial 21th Century Research Institute30
尚未招募
3 期
A Study To See The Effect Of Aragvadha Ointment In Dushta Vrana (Infected Wound) With Special Reference To Microbial LoadCTRI/2024/05/067854Dr Akanksha Sunil Akulwar